Physician profile
Petra Obradovic
NPI 1225265325
$2,130.25
in general payments reported to CMS, 2019-2025
19 companies · $471 in 2025
The $471 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $244 · 2021: $278 · 2022: $232 · 2023: $250 · 2024: $437 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,157.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $397.40 | 2019-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Glaxosmithkline, LLC. | $366.29 | 2019-2025 | Penmenvy, Bexsero |
| Kaleo, INC. | $226.62 | 2019-2023 | Auvi-Q |
| Regeneron Healthcare Solutions, INC. | $161.57 | 2024-2025 | Dupixent |
| Phadia US INC. | $156.04 | 2019-2024 | Immunocap |
| Sanofi Pasteur INC. | $140.12 | 2022-2025 | |
| Cranial Technologies, INC | $118.59 | 2019-2025 | Doc Band |
| Alk-Abello, INC | $116.75 | 2023-2025 | Neffy, Grastek, Odactra |
| Sanofi-Aventis U.S. LLC | $112.59 | 2024-2025 | |
| Pfizer INC. | $95.91 | 2019-2022 | |
| Hologic Sales and Service, LLC | $48.20 | 2022 | |
| Verrica Pharmaceuticals INC. | $46.21 | 2025 | Ycanth |
| Ars Pharmaceuticals Operations, INC. | $28.11 | 2025 | Neffy |
| Genzyme Corporation | $23.20 | 2022 | |
| Ironwood Pharmaceuticals, INC | $22.75 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $22.29 | 2024 | Wegovy |
| Biomarin Pharmaceutical INC. | $20.54 | 2024 | Voxzogo 1.2mg |
| Kowa Pharmaceuticals America, INC. | $15.08 | 2025 | Zoryve |
| Dentsply Sirona INC | $11.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Petra Obradovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.